Literature DB >> 34193165

Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.

Umedjon Ibragimov1, Katherine E Cooper2, Evan Batty3, April M Ballard2, Monica Fadanelli2, Skylar B Gross2, Emma M Klein2, Scott Lockard4, April M Young3, Hannah L F Cooper2.   

Abstract

BACKGROUND: Enrolling sufficient number of people who inject drugs (PWID) into syringe services programs (SSP) is important to curtail outbreaks of drug-related harms. Still, little is known about barriers and facilitators to SSP enrollment in rural areas with no history of such programs. This study's purpose was to develop a grounded theory of the role of the risk environment and individual characteristics of PWID in shaping SSP enrollment in rural Kentucky.
METHODS: We conducted one-on-one semi-structured interviews with 41 clients of 5 SSPs that were established in rural counties in Appalachian Kentucky in 2017-2018. Interviews covered PWID needs, the process of becoming aware of SSPs, and barriers and facilitators to SSP enrollment. Applying constructivist grounded theory methods and guided by the Intersectional Risk Environment Framework (IREF), we applied open, axial and selective coding to develop the grounded theory.
RESULTS: Stigma, a feature of IREF's meso-level social domain, is the main factor hampering SSP enrollment. PWID hesitated to visit SSPs because of internalized stigma and because of anticipated stigma from police, friends, family and healthcare providers. Fear of stigma was often mitigated or amplified by a constellation of meso-level environmental factors related to healthcare (e.g., SSPs) and social (PWID networks) domains and by PWID's individual characteristics. SSPs mitigated stigma as a barrier to enrollment by providing low threshold services in a friendly atmosphere, and by offering their clients program IDs to protect them from paraphernalia charges. SSP clients spread positive information about the program within PWID networks and helped their hesitant peers to enroll by accompanying them to SSPs. Individual characteristics, including child custody, employment or high social status, made certain PWID more susceptible to drug-related stigma and hence more likely to delay SSP enrollment.
CONCLUSIONS: Features of the social and healthcare environments operating at the meso-level, as well as PWID's individual characteristics, appear to enhance or mitigate the effect of stigma as a barrier to SSP enrollment. SSPs opening in locations with high stigma against PWID need to ensure low threshold and friendly services, protect their clients from police and mobilize PWID networks to promote enrollment.

Entities:  

Keywords:  People who inject drugs; Rural Appalachia; Stigma; Syringe services programs

Year:  2021        PMID: 34193165     DOI: 10.1186/s12954-021-00518-z

Source DB:  PubMed          Journal:  Harm Reduct J        ISSN: 1477-7517


  48 in total

1.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

2.  Can syringe exchange serve as a conduit to substance abuse treatment?

Authors:  R Heimer
Journal:  J Subst Abuse Treat       Date:  1998 May-Jun

3.  Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

Authors:  Peter J Neumann; Joshua T Cohen; Milton C Weinstein
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

4.  Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.

Authors:  Carolina Barbosa; Hannah Fraser; Thomas J Hoerger; Alyssa Leib; Jennifer R Havens; April Young; Alex Kral; Kimberly Page; Jennifer Evans; Jon Zibbell; Susan Hariri; Claudia Vellozzi; Lina Nerlander; John W Ward; Peter Vickerman
Journal:  Addiction       Date:  2019-08-02       Impact factor: 6.526

5.  Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree.

Authors:  Stephen C Ijioma; Vasco M Pontinha; David A Holdford; Norman V Carroll
Journal:  J Manag Care Spec Pharm       Date:  2021-02

6.  Needle-exchange attendance and health care utilization promote entry into detoxification.

Authors:  S A Strathdee; D D Celentano; N Shah; C Lyles; V A Stambolis; G Macalino; K Nelson; D Vlahov
Journal:  J Urban Health       Date:  1999-12       Impact factor: 3.671

7.  Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.

Authors:  Keith G Heinzerling; Alex H Kral; Neil M Flynn; Rachel L Anderson; Andrea Scott; Mary L Gilbert; Steven M Asch; Ricky N Bluthenthal
Journal:  J Subst Abuse Treat       Date:  2007-01-09

8.  Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.

Authors:  Trang Quynh Nguyen; Brian W Weir; Don C Des Jarlais; Steven D Pinkerton; David R Holtgrave
Journal:  AIDS Behav       Date:  2014-11

Review 9.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

Authors:  Esther J Aspinall; Dhanya Nambiar; David J Goldberg; Matthew Hickman; Amanda Weir; Eva Van Velzen; Norah Palmateer; Joseph S Doyle; Margaret E Hellard; Sharon J Hutchinson
Journal:  Int J Epidemiol       Date:  2013-12-27       Impact factor: 7.196

10.  Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.

Authors:  Cora L Bernard; Douglas K Owens; Jeremy D Goldhaber-Fiebert; Margaret L Brandeau
Journal:  PLoS Med       Date:  2017-05-24       Impact factor: 11.613

View more
  1 in total

1.  A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics.

Authors:  Monica Fadanelli; Hannah L F Cooper; Patricia R Freeman; April M Ballard; Umed Ibragimov; April M Young
Journal:  Harm Reduct J       Date:  2022-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.